1
|
Vu TH, Kwon M, Ahmed S, Gule-Monroe M, Chen MM, Sun J, Fornage BD, Debnam JM, Edeiken-Monroe B. Diagnostic Accuracy and Scope of Intraoperative Transoral Ultrasound and Transoral Ultrasound-Guided Fine-Needle Aspiration of Retropharyngeal Masses. AJNR Am J Neuroradiol 2019; 40:1960-1964. [PMID: 31582388 DOI: 10.3174/ajnr.a6236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2019] [Accepted: 08/12/2019] [Indexed: 11/07/2022]
Abstract
The use of transoral sonography-guided fine-needle aspiration for intraoperative localization of retropharyngeal masses has been described by Fornage et al. The purpose of this study was to assess the accuracy of this technique. We reviewed the images and medical records of 26 patients with a retropharyngeal lesion suspicious for a metastatic lymph node of Rouviere identified on CT and/or PET/CT. There were 14 patients with a history of thyroid cancer, 7 with mucosal squamous cell carcinoma, 1 with renal cell carcinoma, 1 with parotid acinic cell cancer, 1 with metastatic colon adenocarcinoma, and 2 with no history of cancer. Intraoperative transoral sonography was performed using a commercially available endovaginal transducer. A transoral sonography-guided fine-needle aspiration was performed with a 25-cm-long 20-ga Chiba needle through a needle guide attached to the transducer shaft. Cytopathologic results were categorized as malignant, benign, or nondiagnostic. Transoral sonography and transoral sonography-guided fine-needle aspiration were performed in all patients. A diagnostic specimen was obtained in 25 of 26 (96%) patients with a 100% overall accuracy. Twelve patients underwent subsequent transoral resection of the retropharyngeal mass. In each patient, surgical pathology confirmed the fine-needle aspiration biopsy result. In 4 patients, transoral sonography-guided injection of methylene blue was used to facilitate intraoperative localization of the metastatic retropharyngeal mass. Transoral sonography and transoral sonography-guided fine-needle aspiration of suspicious masses in the retropharyngeal space are highly accurate procedures for identification and cytologic evaluation of benign and metastatic lymph nodes of Rouviere and for presurgical localization.
Collapse
Affiliation(s)
- T H Vu
- From the Section of Neuroradiology (T.H.V., M.K., S.A., M.G.-M., M.M.C., J.M.D., B.E.-M.)
| | - M Kwon
- From the Section of Neuroradiology (T.H.V., M.K., S.A., M.G.-M., M.M.C., J.M.D., B.E.-M.)
| | - S Ahmed
- From the Section of Neuroradiology (T.H.V., M.K., S.A., M.G.-M., M.M.C., J.M.D., B.E.-M.)
| | - M Gule-Monroe
- From the Section of Neuroradiology (T.H.V., M.K., S.A., M.G.-M., M.M.C., J.M.D., B.E.-M.)
| | - M M Chen
- From the Section of Neuroradiology (T.H.V., M.K., S.A., M.G.-M., M.M.C., J.M.D., B.E.-M.)
| | - J Sun
- Department of Biostatistics (J.S.), University of Texas MD Anderson Cancer Center, Houston, Texas
| | - B D Fornage
- Section of Breast Imaging (B.D.F.), Department of Diagnostic Radiology
| | - J M Debnam
- From the Section of Neuroradiology (T.H.V., M.K., S.A., M.G.-M., M.M.C., J.M.D., B.E.-M.)
| | - B Edeiken-Monroe
- From the Section of Neuroradiology (T.H.V., M.K., S.A., M.G.-M., M.M.C., J.M.D., B.E.-M.)
| |
Collapse
|
2
|
Dabaja B, Gule-Monroe M, Gunther J, Milgrom S, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Nastoupil L, Neelapu S, Pinnix C, Fowler N. DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: CAN MRI PATTERN HELP PREDICTING OUTCOME? Hematol Oncol 2019. [DOI: 10.1002/hon.118_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- B. Dabaja
- Radiation Oncology; University of Texas MD Anderson; Houston United States
| | - M. Gule-Monroe
- Neuro-Radiology; The University of Texas MD Anderson; Houston United States
| | - J.R. Gunther
- Radiation Oncology; University of Texas MD Anderson; Houston United States
| | - S. Milgrom
- Radiation Oncology; University of Texas MD Anderson; Houston United States
| | - T. Sheu
- Radiation Oncology; University of Texas MD Anderson; Houston United States
| | - R. Nair
- Medical Oncology-Lymphoma Myeloma; The University of Texas MD Anderson; Houston United States
| | - S. Ahmed
- Medical Oncology-Lymphoma Myeloma; The University of Texas MD Anderson; Houston United States
| | - R. Steiner
- Medical Oncology-Lymphoma Myeloma; The University of Texas MD Anderson; Houston United States
| | - P. Strati
- Medical Oncology-Lymphoma Myeloma; The University of Texas MD Anderson; Houston United States
| | - L. Nastoupil
- Medical Oncology-Lymphoma Myeloma; The University of Texas MD Anderson; Houston United States
| | - S. Neelapu
- Medical Oncology-Lymphoma Myeloma; The University of Texas MD Anderson; Houston United States
| | - C. Pinnix
- Radiation Oncology; University of Texas MD Anderson; Houston United States
| | - N. Fowler
- Medical Oncology-Lymphoma Myeloma; The University of Texas MD Anderson; Houston United States
| |
Collapse
|
3
|
Mastall M, Majd N, Fuller G, Gule-Monroe M, Huse J, Khatua S, Rao G, Sandberg D, Wefel J, Yeboa D, Zaky W, Mahajan A, Puduvalli V, Suki D, Alfaro K, Weathers S, Harrison R, de Groot J, Penas-Prado M. P05.93 Adult medulloblastoma: analysis of use of chemotherapy in clinical practice. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M Mastall
- University of Heidelberg, Heidelberg, Germany
| | - N Majd
- MD Anderson Cancer Center, Houston, TX, United States
| | - G Fuller
- MD Anderson Cancer Center, Houston, TX, United States
| | - M Gule-Monroe
- MD Anderson Cancer Center, Houston, TX, United States
| | - J Huse
- MD Anderson Cancer Center, Houston, TX, United States
| | - S Khatua
- MD Anderson Cancer Center, Houston, TX, United States
| | - G Rao
- MD Anderson Cancer Center, Houston, TX, United States
| | - D Sandberg
- MD Anderson Cancer Center, Houston, TX, United States
| | - J Wefel
- MD Anderson Cancer Center, Houston, TX, United States
| | - D Yeboa
- MD Anderson Cancer Center, Houston, TX, United States
| | - W Zaky
- MD Anderson Cancer Center, Houston, TX, United States
| | - A Mahajan
- Mayo Clinic, Rochester, MN, United States
| | - V Puduvalli
- Ohio State University, Columbus, OH, United States
| | - D Suki
- MD Anderson Cancer Center, Houston, TX, United States
| | - K Alfaro
- MD Anderson Cancer Center, Houston, TX, United States
| | - S Weathers
- MD Anderson Cancer Center, Houston, TX, United States
| | - R Harrison
- MD Anderson Cancer Center, Houston, TX, United States
| | - J de Groot
- MD Anderson Cancer Center, Houston, TX, United States
| | - M Penas-Prado
- MD Anderson Cancer Center, Houston, TX, United States
| |
Collapse
|